Details

The co-expression of estrogen receptors ERα, ERβ, and GPER in endometrial cancer
ID Hojnik, Marko (Author), ID Sinreih, Maša (Author), ID Anko, Maja (Author), ID Hevir-Kene, Neli (Author), ID Knific, Tamara (Author), ID Pirš, Boštjan (Author), ID Frković-Grazio, Snježana (Author), ID Lanišnik-Rižner, Tea (Author)

.pdfPDF - Presentation file, Download (3,68 MB)
MD5: 1F35FEE0939A52EFFFC3F8DBD498FF58
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/24/3/3009 This link opens in a new window

Abstract
Estrogens have important roles in endometrial cancer (EC) and exert biological effects through the classical estrogen receptors (ERs) ERα and ERβ, and the G-protein–coupled ER, GPER. So far, the co-expression of these three types of ERs has not been studied in EC. We investigated ERα, ERβ, GPER mRNA and protein levels, and their intracellular protein distributions in EC tissue and in adjacent control endometrial tissue. Compared to control endometrial tissue, immunoreactivity for ERα in EC tissue was weaker for nuclei with minor, but unchanged, cytoplasmic staining; mRNA and protein levels showed decreased patterns for ERα in EC tissue. For ERβ, across both tissue types, the immunoreactivity was unchanged for nuclei and cytoplasm, although EC tissues again showed lower mRNA and protein levels compared to adjacent control endometrial tissue. The immunoreactivity of GPER as well as mRNA levels of GPER were unchanged across cancer and control endometrial tissues, while protein levels were lower in EC tissue. Statistically significant correlations of estrogen receptor α (ESR1) versus estrogen receptor β (ESR2) and GPER variant 3,4 versus ESR1 and ESR2 was seen at the mRNA level. At the protein level studied with Western blotting, there was significant correlation of ERα versus GPER, and ERβ versus GPER. While in clinical practice the expression of ERα is routinely tested in EC tissue, ERβ and GPER need to be further studied to examine their potential as prognostic markers, provided that specific and validated antibodies are available.

Language:English
Keywords:endometrial cancer, immunohistochemistry, GPER
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:23 str.
Numbering:Vol. 24, iss. 3, art. 3009
PID:20.500.12556/RUL-187752 This link opens in a new window
UDC:618.1
ISSN on article:1422-0067
DOI:10.3390/ijms24033009 This link opens in a new window
COBISS.SI-ID:141173251 This link opens in a new window
Publication date in RUL:16.09.2026
Views:118
Downloads:28
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rak endometrija, imunohistokemija, GPER

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-4135
Name:Molekularne osnove endometrioze in raka endometrija-študije metaboloma

Funder:ARRS - Slovenian Research Agency
Project number:J3-8212
Name:Vloga intrakrinega delovanja estrogenov pri hormonsko odvisnih boleznih ? pomen za zdravljenje

Funder:ARRS - Slovenian Research Agency
Project number:J3-2535
Name:Vloga androgenov pri hormonsko odvisnih boleznih: pomen za diagnostiko in zdravljenje

Funder:ARRS - Slovenian Research Agency
Funding programme:Young Researchers

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back